Industry: Chemical & Material
Published Date: 2026-03-11
Pages: 163 Pages
Report ld: 6178922
Request Sample
Customized Report
Montelukast Sodium Intermediates Market Size(US$)

CAGR 2026-2032
9.7%
Market Size,2032
USD 4,478
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Montelukast Sodium Intermediates market was valued at US$ 2363 million in 2025 and is anticipated to reach US$ 4478 million by 2032, at a CAGR of 9.7% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Montelukast Sodium Intermediates competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Montelukast sodium intermediate is one of the key raw materials used in the production of Montelukast sodium. Montelukast sodium is a drug commonly used to treat allergic asthma and seasonal allergic rhinitis, and belongs to the class of leukotriene receptor antagonists. It mainly blocks the effects of leukotrienes to reduce allergic reactions, thereby relieving asthma symptoms.
The North American market for Montelukast Sodium Intermediates is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Montelukast Sodium Intermediates is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Montelukast Sodium Intermediates include Manus Aktteva Biopharma, Ortin Laboratories, PGShah & Co, VIVAN Life Sciences, Arch Pharmalabs, Actis Generics, Morepen Laboratories, TAPI, MSN Laboratories, Ultratech India, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Montelukast Sodium Intermediates market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Montelukast Sodium Intermediates. The Montelukast Sodium Intermediates market size, estimates, and forecasts are provided in terms of output/shipments (kg) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Montelukast Sodium Intermediates market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Montelukast Sodium Intermediates manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Montelukast Sodium Intermediates manufacturers, including prices, production, value-based market shares, latest development plans, and information on mergers and acquisitions.
Chapter 3: Examines Montelukast Sodium Intermediates production/output and value by region and country, providing a quantitative assessment of market size and growth potential for each region over the next six years.
Chapter 4: Analyzes Montelukast Sodium Intermediates consumption at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national production.
Chapter 5: Analyzes market segments by Type, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 6: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 7: Profiles key players, detailing the fundamentals of major companies, including product production/output, value, price, gross margin, product portfolio/introductions, and recent developments.
Chapter 8: Reviews the industry value chain, including upstream and downstream segments.
Chapter 9: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 10: Summarizes the key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Montelukast Sodium Intermediates Market Overview
1.1 Product Definition
1.2 Montelukast Sodium Intermediates by Type
1.2.1 Global Montelukast Sodium Intermediates Market Value Growth Rate Analysis by Type: 2025 vs 2032
1.2.2 Aromatic Amines
1.2.3 Ethers
1.2.4 Esters
1.2.5 Others
1.3 Montelukast Sodium Intermediates by Application
1.3.1 Global Montelukast Sodium Intermediates Market Value Growth Rate Analysis by Application: 2025 vs 2032
1.3.2 Pharmaceuticals
1.3.3 Scientific Research
1.3.4 Others
1.4 Global Market Growth Prospects
1.4.1 Global Montelukast Sodium Intermediates Production Value Estimates and Forecasts (2021–2032)
1.4.2 Global Montelukast Sodium Intermediates Production Capacity Estimates and Forecasts (2021–2032)
1.4.3 Global Montelukast Sodium Intermediates Production Estimates and Forecasts (2021–2032)
1.4.4 Global Montelukast Sodium Intermediates Market Average Price Estimates and Forecasts (2021–2032)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Montelukast Sodium Intermediates Production Market Share by Manufacturers (2021–2026)
2.2 Global Montelukast Sodium Intermediates Production Value Market Share by Manufacturers (2021–2026)
2.3 Global Key Players of Montelukast Sodium Intermediates, Industry Ranking, 2024 vs 2025
2.4 Global Montelukast Sodium Intermediates Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.5 Global Montelukast Sodium Intermediates Average Price by Manufacturers (2021–2026)
2.6 Global Key Manufacturers of Montelukast Sodium Intermediates, Manufacturing Footprints and Headquarters
2.7 Global Key Manufacturers of Montelukast Sodium Intermediates, Product Offerings and Applications
2.8 Global Key Manufacturers of Montelukast Sodium Intermediates, Date of Entry into the Industry
2.9 Montelukast Sodium Intermediates Market Competitive Situation and Trends
2.9.1 Montelukast Sodium Intermediates Market Concentration Rate
2.9.2 Top 5 and Top 10 Global Montelukast Sodium Intermediates Players Market Share by Revenue
2.10 Mergers & Acquisitions and Expansion
3 Montelukast Sodium Intermediates Production by Region
3.1 Global Montelukast Sodium Intermediates Production Value Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.2 Global Montelukast Sodium Intermediates Production Value by Region (2021–2032)
3.2.1 Global Montelukast Sodium Intermediates Production Value by Region (2021–2026)
3.2.2 Global Forecasted Production Value of Montelukast Sodium Intermediates by Region (2027–2032)
3.3 Global Montelukast Sodium Intermediates Production Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.4 Global Montelukast Sodium Intermediates Production Volume by Region (2021–2032)
3.4.1 Global Montelukast Sodium Intermediates Production by Region (2021–2026)
3.4.2 Global Forecasted Production of Montelukast Sodium Intermediates by Region (2027–2032)
3.5 Global Montelukast Sodium Intermediates Market Price Analysis by Region (2021–2032)
3.6 Global Montelukast Sodium Intermediates Production, Value, and Year-over-Year Growth
3.6.1 North America Montelukast Sodium Intermediates Production Value Estimates and Forecasts (2021–2032)
3.6.2 Europe Montelukast Sodium Intermediates Production Value Estimates and Forecasts (2021–2032)
3.6.3 China Montelukast Sodium Intermediates Production Value Estimates and Forecasts (2021–2032)
3.6.4 Japan Montelukast Sodium Intermediates Production Value Estimates and Forecasts (2021–2032)
4 Montelukast Sodium Intermediates Consumption by Region
4.1 Global Montelukast Sodium Intermediates Consumption Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
4.2 Global Montelukast Sodium Intermediates Consumption by Region (2021–2032)
4.2.1 Global Montelukast Sodium Intermediates Consumption by Region (2021–2026)
4.2.2 Global Montelukast Sodium Intermediates Forecasted Consumption by Region (2027–2032)
4.3 North America
4.3.1 North America Montelukast Sodium Intermediates Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.3.2 North America Montelukast Sodium Intermediates Consumption by Country (2021–2032)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Montelukast Sodium Intermediates Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.4.2 Europe Montelukast Sodium Intermediates Consumption by Country (2021–2032)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Montelukast Sodium Intermediates Consumption Growth Rate by Region: 2021 vs 2025 vs 2032
4.5.2 Asia Pacific Montelukast Sodium Intermediates Consumption by Region (2021–2032)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Montelukast Sodium Intermediates Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.6.2 Latin America, Middle East & Africa Montelukast Sodium Intermediates Consumption by Country (2021–2032)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Montelukast Sodium Intermediates Production by Type (2021–2032)
5.1.1 Global Montelukast Sodium Intermediates Production by Type (2021–2026)
5.1.2 Global Montelukast Sodium Intermediates Production by Type (2027–2032)
5.1.3 Global Montelukast Sodium Intermediates Production Market Share by Type (2021–2032)
5.2 Global Montelukast Sodium Intermediates Production Value by Type (2021–2032)
5.2.1 Global Montelukast Sodium Intermediates Production Value by Type (2021–2026)
5.2.2 Global Montelukast Sodium Intermediates Production Value by Type (2027–2032)
5.2.3 Global Montelukast Sodium Intermediates Production Value Market Share by Type (2021–2032)
5.3 Global Montelukast Sodium Intermediates Price by Type (2021–2032)
6 Segment by Application
6.1 Global Montelukast Sodium Intermediates Production by Application (2021–2032)
6.1.1 Global Montelukast Sodium Intermediates Production by Application (2021–2026)
6.1.2 Global Montelukast Sodium Intermediates Production by Application (2027–2032)
6.1.3 Global Montelukast Sodium Intermediates Production Market Share by Application (2021–2032)
6.2 Global Montelukast Sodium Intermediates Production Value by Application (2021–2032)
6.2.1 Global Montelukast Sodium Intermediates Production Value by Application (2021–2026)
6.2.2 Global Montelukast Sodium Intermediates Production Value by Application (2027–2032)
6.2.3 Global Montelukast Sodium Intermediates Production Value Market Share by Application (2021–2032)
6.3 Global Montelukast Sodium Intermediates Price by Application (2021–2032)
7 Key Companies Profiled
7.1 Manus Aktteva Biopharma
7.1.1 Manus Aktteva Biopharma Montelukast Sodium Intermediates Company Information
7.1.2 Manus Aktteva Biopharma Montelukast Sodium Intermediates Product Portfolio
7.1.3 Manus Aktteva Biopharma Montelukast Sodium Intermediates Production, Value, Price, and Gross Margin (2021–2026)
7.1.4 Manus Aktteva Biopharma Main Business and Markets Served
7.1.5 Manus Aktteva Biopharma Recent Developments/Updates
7.2 Ortin Laboratories
7.2.1 Ortin Laboratories Montelukast Sodium Intermediates Company Information
7.2.2 Ortin Laboratories Montelukast Sodium Intermediates Product Portfolio
7.2.3 Ortin Laboratories Montelukast Sodium Intermediates Production, Value, Price, and Gross Margin (2021–2026)
7.2.4 Ortin Laboratories Main Business and Markets Served
7.2.5 Ortin Laboratories Recent Developments/Updates
7.3 PGShah & Co
7.3.1 PGShah & Co Montelukast Sodium Intermediates Company Information
7.3.2 PGShah & Co Montelukast Sodium Intermediates Product Portfolio
7.3.3 PGShah & Co Montelukast Sodium Intermediates Production, Value, Price, and Gross Margin (2021–2026)
7.3.4 PGShah & Co Main Business and Markets Served
7.3.5 PGShah & Co Recent Developments/Updates
7.4 VIVAN Life Sciences
7.4.1 VIVAN Life Sciences Montelukast Sodium Intermediates Company Information
7.4.2 VIVAN Life Sciences Montelukast Sodium Intermediates Product Portfolio
7.4.3 VIVAN Life Sciences Montelukast Sodium Intermediates Production, Value, Price, and Gross Margin (2021–2026)
7.4.4 VIVAN Life Sciences Main Business and Markets Served
7.4.5 VIVAN Life Sciences Recent Developments/Updates
7.5 Arch Pharmalabs
7.5.1 Arch Pharmalabs Montelukast Sodium Intermediates Company Information
7.5.2 Arch Pharmalabs Montelukast Sodium Intermediates Product Portfolio
7.5.3 Arch Pharmalabs Montelukast Sodium Intermediates Production, Value, Price, and Gross Margin (2021–2026)
7.5.4 Arch Pharmalabs Main Business and Markets Served
7.5.5 Arch Pharmalabs Recent Developments/Updates
7.6 Actis Generics
7.6.1 Actis Generics Montelukast Sodium Intermediates Company Information
7.6.2 Actis Generics Montelukast Sodium Intermediates Product Portfolio
7.6.3 Actis Generics Montelukast Sodium Intermediates Production, Value, Price, and Gross Margin (2021–2026)
7.6.4 Actis Generics Main Business and Markets Served
7.6.5 Actis Generics Recent Developments/Updates
7.7 Morepen Laboratories
7.7.1 Morepen Laboratories Montelukast Sodium Intermediates Company Information
7.7.2 Morepen Laboratories Montelukast Sodium Intermediates Product Portfolio
7.7.3 Morepen Laboratories Montelukast Sodium Intermediates Production, Value, Price, and Gross Margin (2021–2026)
7.7.4 Morepen Laboratories Main Business and Markets Served
7.7.5 Morepen Laboratories Recent Developments/Updates
7.8 TAPI
7.8.1 TAPI Montelukast Sodium Intermediates Company Information
7.8.2 TAPI Montelukast Sodium Intermediates Product Portfolio
7.8.3 TAPI Montelukast Sodium Intermediates Production, Value, Price, and Gross Margin (2021–2026)
7.8.4 TAPI Main Business and Markets Served
7.8.5 TAPI Recent Developments/Updates
7.9 MSN Laboratories
7.9.1 MSN Laboratories Montelukast Sodium Intermediates Company Information
7.9.2 MSN Laboratories Montelukast Sodium Intermediates Product Portfolio
7.9.3 MSN Laboratories Montelukast Sodium Intermediates Production, Value, Price, and Gross Margin (2021–2026)
7.9.4 MSN Laboratories Main Business and Markets Served
7.9.5 MSN Laboratories Recent Developments/Updates
7.10 Ultratech India
7.10.1 Ultratech India Montelukast Sodium Intermediates Company Information
7.10.2 Ultratech India Montelukast Sodium Intermediates Product Portfolio
7.10.3 Ultratech India Montelukast Sodium Intermediates Production, Value, Price, and Gross Margin (2021–2026)
7.10.4 Ultratech India Main Business and Markets Served
7.10.5 Ultratech India Recent Developments/Updates
7.11 Aurobindo Pharma
7.11.1 Aurobindo Pharma Montelukast Sodium Intermediates Company Information
7.11.2 Aurobindo Pharma Montelukast Sodium Intermediates Product Portfolio
7.11.3 Aurobindo Pharma Montelukast Sodium Intermediates Production, Value, Price, and Gross Margin (2021–2026)
7.11.4 Aurobindo Pharma Main Business and Markets Served
7.11.5 Aurobindo Pharma Recent Developments/Updates
7.12 Medopharm
7.12.1 Medopharm Montelukast Sodium Intermediates Company Information
7.12.2 Medopharm Montelukast Sodium Intermediates Product Portfolio
7.12.3 Medopharm Montelukast Sodium Intermediates Production, Value, Price, and Gross Margin (2021–2026)
7.12.4 Medopharm Main Business and Markets Served
7.12.5 Medopharm Recent Developments/Updates
7.13 Nenter & Co., Inc
7.13.1 Nenter & Co., Inc Montelukast Sodium Intermediates Company Information
7.13.2 Nenter & Co., Inc Montelukast Sodium Intermediates Product Portfolio
7.13.3 Nenter & Co., Inc Montelukast Sodium Intermediates Production, Value, Price, and Gross Margin (2021–2026)
7.13.4 Nenter & Co., Inc Main Business and Markets Served
7.13.5 Nenter & Co., Inc Recent Developments/Updates
7.14 Ruiweier Biotechnology
7.14.1 Ruiweier Biotechnology Montelukast Sodium Intermediates Company Information
7.14.2 Ruiweier Biotechnology Montelukast Sodium Intermediates Product Portfolio
7.14.3 Ruiweier Biotechnology Montelukast Sodium Intermediates Production, Value, Price, and Gross Margin (2021–2026)
7.14.4 Ruiweier Biotechnology Main Business and Markets Served
7.14.5 Ruiweier Biotechnology Recent Developments/Updates
7.15 Arromax Pharmatech
7.15.1 Arromax Pharmatech Montelukast Sodium Intermediates Company Information
7.15.2 Arromax Pharmatech Montelukast Sodium Intermediates Product Portfolio
7.15.3 Arromax Pharmatech Montelukast Sodium Intermediates Production, Value, Price, and Gross Margin (2021–2026)
7.15.4 Arromax Pharmatech Main Business and Markets Served
7.15.5 Arromax Pharmatech Recent Developments/Updates
7.16 Alpha Pharmaceutical
7.16.1 Alpha Pharmaceutical Montelukast Sodium Intermediates Company Information
7.16.2 Alpha Pharmaceutical Montelukast Sodium Intermediates Product Portfolio
7.16.3 Alpha Pharmaceutical Montelukast Sodium Intermediates Production, Value, Price, and Gross Margin (2021–2026)
7.16.4 Alpha Pharmaceutical Main Business and Markets Served
7.16.5 Alpha Pharmaceutical Recent Developments/Updates
7.17 Kangfeidi Chemical
7.17.1 Kangfeidi Chemical Montelukast Sodium Intermediates Company Information
7.17.2 Kangfeidi Chemical Montelukast Sodium Intermediates Product Portfolio
7.17.3 Kangfeidi Chemical Montelukast Sodium Intermediates Production, Value, Price, and Gross Margin (2021–2026)
7.17.4 Kangfeidi Chemical Main Business and Markets Served
7.17.5 Kangfeidi Chemical Recent Developments/Updates
7.18 Anqing Rock Pharmaceutical
7.18.1 Anqing Rock Pharmaceutical Montelukast Sodium Intermediates Company Information
7.18.2 Anqing Rock Pharmaceutical Montelukast Sodium Intermediates Product Portfolio
7.18.3 Anqing Rock Pharmaceutical Montelukast Sodium Intermediates Production, Value, Price, and Gross Margin (2021–2026)
7.18.4 Anqing Rock Pharmaceutical Main Business and Markets Served
7.18.5 Anqing Rock Pharmaceutical Recent Developments/Updates
7.19 BioChem Partner
7.19.1 BioChem Partner Montelukast Sodium Intermediates Company Information
7.19.2 BioChem Partner Montelukast Sodium Intermediates Product Portfolio
7.19.3 BioChem Partner Montelukast Sodium Intermediates Production, Value, Price, and Gross Margin (2021–2026)
7.19.4 BioChem Partner Main Business and Markets Served
7.19.5 BioChem Partner Recent Developments/Updates
7.20 Dongyue Pharma
7.20.1 Dongyue Pharma Montelukast Sodium Intermediates Company Information
7.20.2 Dongyue Pharma Montelukast Sodium Intermediates Product Portfolio
7.20.3 Dongyue Pharma Montelukast Sodium Intermediates Production, Value, Price, and Gross Margin (2021–2026)
7.20.4 Dongyue Pharma Main Business and Markets Served
7.20.5 Dongyue Pharma Recent Developments/Updates
7.21 WeiShi Reagent
7.21.1 WeiShi Reagent Montelukast Sodium Intermediates Company Information
7.21.2 WeiShi Reagent Montelukast Sodium Intermediates Product Portfolio
7.21.3 WeiShi Reagent Montelukast Sodium Intermediates Production, Value, Price, and Gross Margin (2021–2026)
7.21.4 WeiShi Reagent Main Business and Markets Served
7.21.5 WeiShi Reagent Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Montelukast Sodium Intermediates Industry Chain Analysis
8.2 Montelukast Sodium Intermediates Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Montelukast Sodium Intermediates Production Modes and Processes
8.4 Montelukast Sodium Intermediates Sales and Marketing
8.4.1 Montelukast Sodium Intermediates Sales Channels
8.4.2 Montelukast Sodium Intermediates Distributors
8.5 Montelukast Sodium Intermediates Customer Analysis
9 Montelukast Sodium Intermediates Market Dynamics
9.1 Montelukast Sodium Intermediates Industry Trends
9.2 Montelukast Sodium Intermediates Market Drivers
9.3 Montelukast Sodium Intermediates Market Challenges
9.4 Montelukast Sodium Intermediates Market Restraints
9.5 Impact of U.S. Tariffs
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Montelukast Sodium Intermediates market is projected to grow from US$ 2363 million in 2025 to US$ 4478 million by 2032, at a CAGR of 9.7% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-11
Pages: 194
USD 4900.00
(Single User License)
The global Montelukast Sodium Intermediates market size was US$ 2363 million in 2025 and is forecast to reach a readjusted size of US$ 4478 million by 2032 with a CAGR of 9.7% during the forecast period 2026-2032.
Published Date: 2026-03-11
Pages: 119
USD 4250.00
(Single User License)
The global market for Montelukast Sodium Intermediates was estimated to be worth US$ 2363 million in 2025 and is projected to reach US$ 4478 million, growing at a CAGR of 9.7% from 2026 to 2032.
Published Date: 2026-03-08
Pages: 161
USD 3950.00
(Single User License)
Valued at US$ 2363 million in 2024, the global Montelukast Sodium Intermediates market is forecast to reach US$ 4118 million by 2030, at a CAGR of 9.7% during the forecast period.
Published Date: 2025-02-28
Pages: 193
USD 4900.00
(Single User License)
The global Montelukast Sodium Intermediates market size was US$ 2154 million in 2024 and is forecast to a readjusted size of US$ 4118 million by 2031 with a CAGR of 9.7% during the forecast period 2025-2031.
Published Date: 2025-02-28
Pages: 115
USD 4250.00
(Single User License)
The global market for Montelukast Sodium Intermediates was valued at US$ 2154 million in the year 2024 and is projected to reach a revised size of US$ 4118 million by 2031, growing at a CAGR of 9.7% during the forecast period.
Published Date: 2025-02-28
Pages: 124
USD 2900.00
(Single User License)
The global market for Montelukast Sodium Intermediates was estimated to be worth US$ 2154 million in 2024 and is forecast to a readjusted size of US$ 4118 million by 2031 with a CAGR of 9.7% during the forecast period 2025-2031.
Published Date: 2025-02-28
Pages: 155
USD 3950.00
(Single User License)
The global Montelukast Sodium Intermediates market is projected to grow from US$ 2363 million in 2025 to US$ 4478 million by 2032, at a CAGR of 9.7% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-11
Pages: 194
The global Montelukast Sodium Intermediates market size was US$ 2363 million in 2025 and is forecast to reach a readjusted size of US$ 4478 million by 2032 with a CAGR of 9.7% during the forecast period 2026-2032.
Published: 2026-03-11
Pages: 119
The global market for Montelukast Sodium Intermediates was estimated to be worth US$ 2363 million in 2025 and is projected to reach US$ 4478 million, growing at a CAGR of 9.7% from 2026 to 2032.
Published: 2026-03-08
Pages: 161
Valued at US$ 2363 million in 2024, the global Montelukast Sodium Intermediates market is forecast to reach US$ 4118 million by 2030, at a CAGR of 9.7% during the forecast period.
Published: 2025-02-28
Pages: 193
The global Montelukast Sodium Intermediates market size was US$ 2154 million in 2024 and is forecast to a readjusted size of US$ 4118 million by 2031 with a CAGR of 9.7% during the forecast period 2025-2031.
Published: 2025-02-28
Pages: 115
The global market for Montelukast Sodium Intermediates was valued at US$ 2154 million in the year 2024 and is projected to reach a revised size of US$ 4118 million by 2031, growing at a CAGR of 9.7% during the forecast period.
Published: 2025-02-28
Pages: 124
The global market for Montelukast Sodium Intermediates was estimated to be worth US$ 2154 million in 2024 and is forecast to a readjusted size of US$ 4118 million by 2031 with a CAGR of 9.7% during the forecast period 2025-2031.
Published: 2025-02-28
Pages: 155
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now